Large-scale testing (Phase 3)Study completedNCT00607243What this trial is testingSafety and Efficacy of CJ-50300 in Healthy VolunteersWho this might be right forSmallpox Seoul National University Hospital 123
Testing effectiveness (Phase 2)Study completedNCT00026611What this trial is testingDryvax Vaccine Against Smallpox in Previously Unvaccinated AdultsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Looking for participantsNCT05745987What this trial is testingSmallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCTWho this might be right forMonkeypox McMaster University 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT02977715What this trial is testingJYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the CongoWho this might be right forMonkeypox Virus Infection Centers for Disease Control and Prevention 1,600
Testing effectiveness (Phase 2)Ended earlyNCT04410874What this trial is testingImvamune Vaccine for the Treatment of Non-melanoma Skin CancerWho this might be right forNon-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma Ivan Litvinov 1
Early research (Phase 1)Study completedNCT00001043What this trial is testingA Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT01158157What this trial is testingVA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIVWho this might be right forSmallpox Vaccine Adverse Reaction Emergent BioSolutions 25
Not applicableStudy completedNCT01540929What this trial is testingPost-licensure Department of Defense (DOD) Screening Accuracy Study in Military PersonnelWho this might be right forSmallpox Emergent BioSolutions 5,001
Early research (Phase 1)Study completedNCT05762523What this trial is testingSafety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 YearsWho this might be right forSmallpoxMonkeypoxCowpox+1 more Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 60
Testing effectiveness (Phase 2)Study completedNCT00316524What this trial is testingA Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy SubjectsWho this might be right forSmallpox Bavarian Nordic 745
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549530What this trial is testingOpen-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus InfectionsWho this might be right forMonkeypox (Mpox) Bavarian Nordic 460
Testing effectiveness (Phase 2)Looking for participantsNCT07379580What this trial is testingClinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in AfricaWho this might be right forMpox (Monkeypox)SmallpoxOrthopoxvirus Infection BioNTech SE 310
Large-scale testing (Phase 3)Looking for participantsNCT06844487What this trial is testingPhase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRCWho this might be right forMpox (Monkeypox)VaccinationImmunogenicity+3 more Jean-Pierre Van geertruyden 344
Early research (Phase 1)Study completedNCT00082446What this trial is testingCombination Study With MVA BN and DryvaxWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 91
Early research (Phase 1)Study completedNCT00002261What this trial is testingA Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated VolunteersWho this might be right forHIV Infections Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00053495What this trial is testingEffect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationWho this might be right forSmallpox Emergent BioSolutions 353
Testing effectiveness (Phase 2)Study completedNCT00032708What this trial is testingDryvax Dilution-Prev Vacc AdultsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT00079820What this trial is testingSafety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in AdultsWho this might be right forSmallpox Sanofi Pasteur, a Sanofi Company 110
Early research (Phase 1)Ended earlyNCT00282581What this trial is testingSafety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia NaiveWho this might be right forHIV InfectionsSmallpox Sanofi Pasteur, a Sanofi Company 2
Early research (Phase 1)Study completedNCT00000767What this trial is testingA Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 18